Story
SpaceX Stock Nears IPO Price, Testing Investor Confidence and Market for New Listings

Summary
Shares of Elon Musk's SpaceX are trading just above their initial public offering price, raising concerns about lofty tech valuations and potentially complicating the plans for other major companies eyeing the public markets.
Shares of SpaceX are hovering near their initial public offering price after a period of volatile trading, turning one of the year's most anticipated market debuts into a critical test of investor confidence. The stock closed Tuesday at $136.08, down 2.2% and just above its $135 offer price, marking its lowest closing level since its June 12 listing.
A Psychological Test for the Market
After debuting, Elon Musk's aerospace and technology company initially soared, at one point reaching a valuation well above $2 trillion. However, the stock has since slipped from its $150 opening price, reflecting broader concerns about high valuations in the technology sector.
A drop below the IPO price would represent a significant "psychological blow," according to Matthew Maley, chief market strategist at Miller Tabak. Maley told Reuters that such a move could fuel a narrative that the stock's initial surge was driven by "fluff, on speculation, on froth, and not on real fundamentals."
Implications for Future IPOs
SpaceX's performance is being closely monitored by other private companies, such as OpenAI and Anthropic, that are reportedly considering public listings. Greg Halter, director of research at Carnegie Investment Counsel, noted that companies and their investment banks are watching carefully, as "no one wants an IPO to flop."
AdHalter suggested that sustained weakness in SpaceX could lead other firms to pull their offerings rather than accept lower valuations. However, Ryan Lee, senior vice president at Direxion, offered a different perspective, arguing that the intense competition and capital needs in fields like AI might push companies to accelerate their IPO plans to get ahead of rivals.
Price Discovery and Retail Risk
Analysts caution that post-IPO volatility is a normal part of the market's price discovery process. Gabriel Shahin, CEO at Falcon Wealth Planning, described a potential dip below $135 as "normal, albeit painful" market mechanics, particularly as early investors and employees begin to sell shares after lockup periods expire.
This volatility could disproportionately affect retail investors, who received an estimated 20% of the IPO allocation. Shahin warned that many novice investors approached SpaceX with a "'meme stock' mentality," and losses could fuel perceptions that markets are tilted in favor of insiders. The company's first earnings report is expected to be the next major test for the stock.
Read next
More on Stocks
Apple's Tim Cook Views Australia's Social Media Curbs as 'World-Leading,' PM Albanese Says
Apple Executive Chair Tim Cook praised Australia's pioneering online safety measures as "world-leading," according to Prime Minister Anthony Albanese following a meeting at the tech giant's California headquarters.

Venezuela's Interim Government Signs Energy MOU with TotalEnergies
Venezuela's interim government signed a memorandum of understanding with French energy major TotalEnergies, the latest in a series of deals aimed at attracting foreign investment back into the nation's vast oil sector.

Huawei Unveils Advanced Power and Cooling Solutions for AI Data Centers
Huawei has launched a new suite of energy infrastructure and thermal management products for AI data centers, signaling a strategic shift towards integrated power storage and intelligent liquid cooling systems to meet the demands of high-density computing.

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.